-
公开(公告)号:US20100234566A1
公开(公告)日:2010-09-16
申请号:US12727653
申请日:2010-03-19
Applicant: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
Inventor: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
IPC: C07K1/08
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to an improved process for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate. The process comprises: (a) polymerizing a mixture of N-carboxyanhydride of L-tyrosine, N-carboxyanhydride of L-alanine, N-carboxyanhydride of a protected L-glutamate and N-carboxyanhydride of a protected L-lysine, in a polar aprotic solvent in the presence of an initiator, to form a protected polypeptide; (b) admixing an acid with the protected polypeptide formed in Step (a) and a solvent, to form a product; and (c) admixing a substance selected from the group consisting of an alkali or alkaline earth metal hydroxide, a carbonate, a hydrogencarbonate, and mixtures thereof, with the product formed in Step (b), and a solvent or a mixture of a solvent and water, to form a deprotected polypeptide or a pharmaceuticaly acceptable salt thereof.
Abstract translation: 本发明涉及制备包含L-酪氨酸,L-丙氨酸,L-谷氨酸和L-赖氨酸的多肽或其药学上可接受的盐的改进方法。 多肽或其药学上可接受的盐优选为醋酸格拉司他。 该方法包括:(a)将L-酪氨酸的N-羧酸酐,L-丙氨酸的N-羧酸酐,受保护的L-谷氨酸的N-羧酸酐和受保护的L-赖氨酸的N-羧酸酐的极性 在引发剂存在下的非质子溶剂,以形成受保护的多肽; (b)将酸与步骤(a)中形成的被保护的多肽和溶剂混合以形成产物; 和(c)将选自碱金属或碱土金属氢氧化物,碳酸盐,碳酸氢盐及其混合物的物质与步骤(b)中形成的产物和溶剂或溶剂的混合物 和水,以形成去保护的多肽或其药学上可接受的盐。
-
公开(公告)号:US08729229B2
公开(公告)日:2014-05-20
申请号:US12726571
申请日:2010-03-18
Applicant: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
Inventor: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to processes for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate.
Abstract translation: 本发明涉及制备包含L-酪氨酸,L-丙氨酸,L-谷氨酸和L-赖氨酸的多肽或其药学上可接受的盐的方法。 多肽或其药学上可接受的盐优选为醋酸格拉司他。
-
3.
公开(公告)号:US07071338B2
公开(公告)日:2006-07-04
申请号:US10722085
申请日:2003-11-25
Applicant: David W. Boykin , Mariappan Anbazhagan , Richard R. Tidwell
Inventor: David W. Boykin , Mariappan Anbazhagan , Richard R. Tidwell
IPC: C07D207/335 , C07D307/52 , C07D333/22
CPC classification number: C07D307/54
Abstract: Bis-aryl diamidoxime compounds, such as 2,5-bis [4-hydroxy and 4-O-alkylamidinophenyl] furans, can be prepared from 2,5-bis tri-alkylstannanes via a one step palladium-catalyzed cross reaction. Bis-aryl diamidoxime compounds, such as 2,5-bis [4-hydroxy and 4-O-alkylamidinophenyl]furans, are useful as therapeutic compounds. The disclosed process is scalable, simpler, more economic and more feasible than other presently known methods of preparing 2,5-bis [4-hydroxy and 4-O-alkylamidinophenyl]furans and other bis-aryl diamidoxime compounds.
Abstract translation: 双芳基二肟化合物,如2,5-双[4-羟基和4-O-烷基脒基苯基]呋喃,可以通过一步钯催化的交叉反应由2,5-双三烷基锡烷制备。 双芳基二肟化合物,例如2,5-双[4-羟基和4-O-烷基脒基苯基]呋喃,可用作治疗化合物。 所公开的方法比其它目前已知的制备2,5-双[4-羟基和4-O-烷基脒基苯基]呋喃和其它双芳基二肟基化合物的方法是可扩展的,更简单的,更经济的和更可行的。
-
公开(公告)号:US08536305B2
公开(公告)日:2013-09-17
申请号:US11904422
申请日:2007-09-27
Applicant: Anup K Ray , Hiren V Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R Patel , Ingolf Macher
Inventor: Anup K Ray , Hiren V Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R Patel , Ingolf Macher
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to an improved process for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate. The process comprises: (a) polymerizing a mixture of N-carboxyanhydride of L-tyrosine, N-carboxyanhydride of L-alanine, N-carboxyanhydride of a protected L-glutamate and N-carboxyanhydride of a protected L-lysine, in a polar aprotic solvent in the presence of an initiator, to form a protected polypeptide; (b) admixing an acid with the protected polypeptide formed in Step (a) and a solvent, to form a product; and (c) admixing a substance selected from the group consisting of an alkali or alkaline earth metal hydroxide, a carbonate, a hydrogencarbonate, and mixtures thereof, with the product formed in Step (b), and a solvent or a mixture of a solvent and water, to form a deprotected polypeptide or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明涉及制备包含L-酪氨酸,L-丙氨酸,L-谷氨酸和L-赖氨酸的多肽或其药学上可接受的盐的改进方法。 多肽或其药学上可接受的盐优选为醋酸格拉司他。 该方法包括:(a)将L-酪氨酸的N-羧酸酐,L-丙氨酸的N-羧酸酐,受保护的L-谷氨酸的N-羧酸酐和受保护的L-赖氨酸的N-羧基酐的极性 在引发剂存在下的非质子溶剂,以形成受保护的多肽; (b)将酸与步骤(a)中形成的被保护的多肽和溶剂混合以形成产物; 和(c)将选自碱金属或碱土金属氢氧化物,碳酸盐,碳酸氢盐及其混合物的物质与步骤(b)中形成的产物和溶剂或溶剂的混合物 和水,以形成去保护的多肽或其药学上可接受的盐。
-
公开(公告)号:US20080021200A1
公开(公告)日:2008-01-24
申请号:US11904422
申请日:2007-09-27
Applicant: Anup Ray , Hiren Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra Patel , Ingolf Macher
Inventor: Anup Ray , Hiren Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra Patel , Ingolf Macher
IPC: C07K16/00
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to an improved process for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate. The process comprises: (a) polymerizing a mixture of N-carboxyanhydride of L-tyrosine, N-carboxyanhydride of L-alanine, N-carboxyanhydride of a protected L-glutamate and N-carboxyanhydride of a protected L-lysine, in a polar aprotic solvent in the presence of an initiator, to form a protected polypeptide; (b) admixing an acid with the protected polypeptide formed in Step (a) and a solvent, to form a product; and (c) admixing a substance selected from the group consisting of an alkali or alkaline earth metal hydroxide, a carbonate, a hydrogencarbonate, and mixtures thereof, with the product formed in Step (b), and a solvent or a mixture of a solvent and water, to form a deprotected polypeptide or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明涉及制备包含L-酪氨酸,L-丙氨酸,L-谷氨酸和L-赖氨酸的多肽或其药学上可接受的盐的改进方法。 多肽或其药学上可接受的盐优选为醋酸格拉司他。 该方法包括:(a)将L-酪氨酸的N-羧酸酐,L-丙氨酸的N-羧酸酐,受保护的L-谷氨酸的N-羧酸酐和受保护的L-赖氨酸的N-羧酸酐的极性 在引发剂存在下的非质子溶剂,以形成受保护的多肽; (b)将酸与步骤(a)中形成的被保护的多肽和溶剂混合以形成产物; 和(c)将选自碱金属或碱土金属氢氧化物,碳酸盐,碳酸氢盐及其混合物的物质与步骤(b)中形成的产物和溶剂或溶剂的混合物 和水,以形成去保护的多肽或其药学上可接受的盐。
-
公开(公告)号:US20100234272A1
公开(公告)日:2010-09-16
申请号:US12726571
申请日:2010-03-18
Applicant: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
Inventor: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to an improved process for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate. The process comprises: (a) polymerizing a mixture of N-carboxyanhydride of L-tyrosine, N-carboxyanhydride of L-alanine, N-carboxyanhydride of a protected L-glutamate and N-carboxyanhydride of a protected L-lysine, in a polar aprotic solvent in the presence of an initiator, to form a protected polypeptide; (b) admixing an acid with the protected polypeptide formed in Step (a) and a solvent, to form a product; and (c) admixing a substance selected from the group consisting of an alkali or alkaline earth metal hydroxide, a carbonate, a hydrogencarbonate, and mixtures thereof, with the product formed in Step (b), and a solvent or a mixture of a solvent and water, to form a deprotected polypeptide or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20100174048A1
公开(公告)日:2010-07-08
申请号:US12727758
申请日:2010-03-19
Applicant: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
Inventor: Anup Kumar Ray , Hiren Kumar V. Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra R. Patel , Ingolf Macher
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to an improved process for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate. The process comprises: (a) polymerizing a mixture of N-carboxyanhydride of L-tyrosine, N-carboxyanhydride of L-alanine, N-carboxyanhydride of a protected L-glutamate and N-carboxyanhydride of a protected L-lysine, in a polar aprotic solvent in the presence of an initiator, to form a protected polypeptide; (b) admixing an acid with the protected polypeptide formed in Step (a) and a solvent, to form a product; and (c) admixing a substance selected from the group consisting of an alkali or alkaline earth metal hydroxide, a carbonate, a hydrogencarbonate, and mixtures thereof, with the product formed in Step (b), and a solvent or a mixture of a solvent and water, to form a deprotected polypeptide or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明涉及制备包含L-酪氨酸,L-丙氨酸,L-谷氨酸和L-赖氨酸的多肽或其药学上可接受的盐的改进方法。 多肽或其药学上可接受的盐优选为醋酸格拉司他。 该方法包括:(a)将L-酪氨酸的N-羧酸酐,L-丙氨酸的N-羧酸酐,受保护的L-谷氨酸的N-羧酸酐和受保护的L-赖氨酸的N-羧酸酐的极性 在引发剂存在下的非质子溶剂,以形成受保护的多肽; (b)将酸与步骤(a)中形成的被保护的多肽和溶剂混合以形成产物; 和(c)将选自碱金属或碱土金属氢氧化物,碳酸盐,碳酸氢盐及其混合物的物质与步骤(b)中形成的产物和溶剂或溶剂的混合物 和水,以形成去保护的多肽或其药学上可接受的盐。
-
公开(公告)号:US20060154862A1
公开(公告)日:2006-07-13
申请号:US11262122
申请日:2005-10-28
Applicant: Anup Ray , Hiren Kumar Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra Patel , Ingolf Macher
Inventor: Anup Ray , Hiren Kumar Patel , Johannes Ludescher , Mariappan Anbazhagan , Mahendra Patel , Ingolf Macher
CPC classification number: C08G69/10 , A61K38/00 , C07K14/001
Abstract: The present invention relates to processes for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L-tyrosine, L-alanine, L-glutamate and L-lysine. The polypeptide or pharmaceutically acceptable salt thereof is preferably glatiramer acetate.
Abstract translation: 本发明涉及制备包含L-酪氨酸,L-丙氨酸,L-谷氨酸和L-赖氨酸的多肽或其药学上可接受的盐的方法。 多肽或其药学上可接受的盐优选为醋酸格拉司他。
-
-
-
-
-
-
-